• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

AZD 4017

CAS No. 1024033-43-9

AZD 4017 ( AZD4017 )

产品货号. M10111 CAS No. 1024033-43-9

AZD4017 是一种有效、选择性、可口服生物利用的人 11β-HSD1,IC50 为 7 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1320 有现货
10MG ¥2341 有现货
25MG ¥4682 有现货
50MG ¥6747 有现货
100MG ¥9315 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    AZD 4017
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    AZD4017 是一种有效、选择性、可口服生物利用的人 11β-HSD1,IC50 为 7 nM。
  • 产品描述
    AZD4017 is a potent, selective, and orally bioavailable human 11β-HSD1 with IC50 of 7 nM, shows no significant activity against 11β-HSD1 and 17β-HSD1, 17β-HSD3 (IC50>30 uM); AZD4017 is inactive (<25% inhibition at 10 μM) against Cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4), and lower potency against the mouse, rat and dog 11β-HSD1 (IC50=750-4000 nM); demonstrates the dose dependent inhibition of 11β-HSD1 in vivo.Cushing Disease Phase 2 Clinical.
  • 体外实验
    AZD 4017 displays excellent selectivity versus the related enzymes 11-βHSD2, 17β-HSD1, 17β-HSD3 (all IC50>30 μM) and shows no measurable activity against the glucocorticoid and mineralocorticoid receptors. Despite having high potency for the human form of 11β-HSD1, AZD 4017 shows much reduced activity across species with the exception of cynomolgous monkey (IC50=0.029 μM). Additionally, as it is believed that adipose is a key target organ, inhibition of 11β-HSD1 activity is measured in isolated human adipocytes from nondiabetic volunteers. AZD 4017 is shown to be a potent inhibitor in this key target tissue (IC50=0.002 μM) in good agreement with the enzyme potency, thus providing some confidence that AZD 4017 is not restricted from adipose tissue by the fact that it was acidic.
  • 体内实验
    Since AZD 4017 has lower potency against the mouse enzyme, only a limited number of preclinical pharmacodynamic measurements are performed. Increasing the dose further led to a maximal effect of approximately 70% inhibition at 1500 mg/kg, equivalent to 10×IC50 in the mouse, demonstrating the dose dependent inhibition of 11β-HSD1 by AZD 4017 in this model.
  • 同义词
    AZD4017
  • 通路
    Metabolic Enzyme/Protease
  • 靶点
    11β-HSD
  • 受体
    11β-HSD
  • 研究领域
    Endocrinology
  • 适应症
    Cushing Disease

化学信息

  • CAS Number
    1024033-43-9
  • 分子量
    419.58
  • 分子式
    C22H33N3O3S
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 125 mg/mL (297.92 mM)
  • SMILES
    O=C(O)C[C@H]1CN(C2=NC(SCCC)=C(C(NC3CCCCC3)=O)C=C2)CCC1
  • 化学全称
    2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Scott JS, et al. J Med Chem. 2012 Jun 28;55(12):5951-64.
产品手册
关联产品
  • BI 187004

    BI 187004 (VTP-34072) 是一种新型有效的选择性 11β-羟基类固醇脱氢酶 1 (11β-HSD1) 抑制剂,旨在治疗 2 型糖尿病 (T2D)。

  • ASP3662

    ASP3662 是一种有效、选择性、CNS 渗透性、口服活性的 11β-HSD1 抑制剂,对人、小鼠和大鼠 11β-HSD1 的 Ki 分别为 5.3、2.6 和 23 nM。

  • BVT-2733

    小鼠 11β-HSD1 的非甾体异构体选择性抑制剂,Ki 为 1 uM。